Institut Pasteur Preclinical Study: Ivermectin a Powerful Immunomodulatory Drug Targeting SARS-CoV-2
14/07/2021 No Comments
The French scientists concluded, “This study supports the use of immunomodulatory drugs such as ivermectin, to improve the clinical condition of SARS-CoV-infected patients.”